Eric Tobin has been announced as CEO of N2 Biomedical, a company providing coating and surface treatment for medical devices, according to a Dec. 2 press release.
Biologics
A landmark clinical trial was announced in November when a $9 million grant was provided for the first human study using stem cells to treat a spinal disorder that occurs in babies in the womb.
Voters approved a proposition to provide $5.5 billion for stem cell research by the California Institute of Regenerative Medicine, according to a Nov. 13 press release.
The first human clinical trial using stem cells to treat spina bifida has been made possible thanks to a $9 million grant provided Nov. 12 by the California Institute for Regenerative Medicine.
CelluBridge, a spinal cord scaffold implant, has received the FDA's breakthrough device designation.
Advertisement
A man who had shoulder pain turned to stem cells to aid his recovery from rotator cuff surgery, according to a Nov. 11 report from ABC12.
Cerapedics' i-Factor+ Matrix is now available for surgical implantation in Canada.
Cells in cellular bone matrix products do not improve fusion or bone formation, according to results of a preclinical SeaSpine study published in The Journal of Bone and Joint Surgery.
The American Academy of Orthopaedic Surgeons on Oct. 15 introduced the AAOS Biologics Dashboard to help physicians keep up to date with the approval status of biologic innovations.
A Wisconsin stem cell clinic has been cautioned by the FDA for marketing intrathecal and intravenous injections of human stem cell and tissue-based products for a variety of neurologic conditions, according to the Regulatory Affairs Professionals Society.